A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 3, 2010, Pages 251-256

  Marsh, Robert De W ^a   George, Thomas J ^a   Siddiqui, Tariq ^a   Mendenhall, William M ^a   Zlotecki, Robert A ^a   Grobmyer, Stephen ^a   Hochwald, Steven ^a   Chang, Myron ^a   Larson, Bradley ^b   King, Judy ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Northwest Georgia Oncology Centers PC   (United States)

Author keywords

Accelerated hyperfractionated radiation; Capecitabine; Rectal cancer

Indexed keywords

CAPECITABINE;

ABDOMINAL PAIN; ADULT; AGED; ANOPLASTY; ANUS SPHINCTER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSTIPATION; DEHYDRATION; DESQUAMATION; DIARRHEA; DRUG ERUPTION; DRUG FEVER; EVENING DOSAGE; FATIGUE; FEMALE; FLATULENCE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; MALE; MORNING DOSAGE; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM PAIN; SIDE EFFECT; SODIUM BLOOD LEVEL; TASTE DISORDER; TUMOR REGRESSION; URINARY FREQUENCY; WEIGHT REDUCTION;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DIARRHEA; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PRODRUGS; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 77953352084     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181a650e8     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts and Figures. American Cancer Society; 2008. www.acs.org
2. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
3. Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol. 2001;19:2282-2292.
4. Van CE, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2001;19:4097-4106.
5. Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res. 1999;5:2948-2953.
6. Kocakova I, Svoboda M, Kubosova K, et al. Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma. Neoplasma. 2007;54:447-453.
7. de Bruin AF, Nuyttens JJ, Ferenschild FT, et al. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med. 2008;66: 71-76.
8. Dupuis O, Vie B, Lledo G, et al. Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study. Oncology. 2007;73:169-176.
9. Glynne-Jones R, Debus J. Improving chemoradiotherapy in rectal cancer. Oncologist. 2001;6(suppl 4):29-34.
10. Korkolis DP, Boskos CS, Plataniotis GD, et al. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res. 2007;27(1B):541-545.
11. Lay GC, Caraul B, Dessi M, et al. Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma. J Exp Clin Cancer Res. 2007;26:61-70.
12. Koeberle D, Burkhard R, von MR, et al. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. Br J Cancer. 2008; 98:1204-1209.
13. Desai SP, El-Rayes BF, Ben-Josef E, et al. A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. Am J Clin Oncol. 2007;30:340-345. (Pubitemid 47356676)
14. Craven I, Crellin A, Cooper R, et al. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333-1337.
15. Cox JD. Fractionation: a paradigm for clinical research in radiation oncology. Int J Radiat Oncol Biol Phys. 1987;13:1271-1281.
16. Million RR, Parsons JT, Cassisi NJ. Twice-a-day irradiation technique for squamous cell carcinomas of the head and neck. Cancer. 1985;55(suppl 9):2096-2099.
17. Parsons JT, Mendenhall WM, Cassisi NJ, et al. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys. 1988;14:649-658.
18. Pinto LH, Canary PC, Araujo CM, et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1991;21: 557-562.
19. Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265-271.
20. Thames HD Jr, Peters LJ, Withers HR, et al. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys. 1983;9:127-138.
21. Withers HR. Biologic basis for altered fractionation schemes. Cancer. 1985; 55(suppl 9):2086-2095.
22. Allal AS, Bieri S, Brundler MA, et al. Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trial. Int J Radiat Oncol Biol Phys. 2002;54:1076-1081.
23. Nabhan C, Ragam A, Samuels B, et al. Mitomycin-C/5-fluorouracil/ leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up. Clin Colorectal Cancer. 2007; 6:436-441.
24. Ceelen W, Boterberg T, Pattyn P, et al. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ann Surg Oncol. 2007;14:424-431.
25. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457-460.
26. DCTD NND. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events. DCTD NND; 2008. www.ctep.cancer.gov
27. O'Neil BH, Tepper JE. Current options for the management of rectal cancer. Curr Treat Options Oncol. 2007;8:331-338.
28. Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242:472-477.
29. Xeloda Investigator Drug Brochure (Ro 09-1978). Version 6; 2002.